Julia Wellin, MD

Dr. Justin Uzl is double board-certified in adult and consultation liaison psychiatry. His fellowship training helped him gain greater insight into the interface between medicine and mental healthcare. He has been practicing for seven years and has worked closely with individuals with co-occurring chronic medical issues, specifically organ transplantation. Dr. Uzl takes a holistic approach to mental healthcare combining medication management, psychotherapy, and lifestyle modifications to help his patients achieve a quality of life that allows them to pursue their goals. He sees the position of the psychiatrist as helping to educate and guide patients, allowing them to take an active role in their own recovery. Dr. Uzl believes diversity is a strength and embraces providing high quality services that affirm the dignity, worth and value of all individuals including the LGBTQ+ community. Dr. Uzl takes an evidence-based approach in his treatment of individuals suffering with depression, anxiety, trauma, difficulty focusing and concentrating, sleep issues, and interpersonal problems. He utilizes insight-oriented care, believing that gaining understanding of a person's feelings, thoughts, and actions will provide them the knowledge needed to make the positive change they desire. Therapy may be a key part of a person's treatment, and if greater frequency is needed outside of sessions with Dr. Uzl, he will refer and collaborate with a psychotherapist to help maximize a patient's success.

Dr. Justine Sever Chilelli, DO, earned her medical degree from the Lake Erie College of Osteopathic Medicine and completed her psychiatry residency and child and adolescent fellowship at the University of South Florida. She is board certified in General Psychiatry and Child and Adolescent Psychiatry. Her experience includes treating children, adolescents, and adults across outpatient, inpatient, consultation-liaison, school-based, and residential settings.

Dr. Chilelli values a collaborative, team-based approach where she and her patients work together to build a treatment plan. She emphasizes open and honest communication, aiming to improve quality of life and reduce the impact of mental health symptoms.

In the initial appointment, Dr. Chilelli focuses on understanding each patient’s history, concerns, and goals. She then develops individualized treatment plans that align with those goals, ensuring care that is thoughtful, supportive, and tailored to each patient’s needs.

Dr. Anil Joseph (AJ) Kulangara completed additional training in Psychiatry at the University of Washington after working primarily in women’s health, primary care, and military medicine as a Battalion Surgeon in the United States Army.  Following his military service, he trained in Psychiatry and served the mental health needs of our Veteran population. He is excited to now bring his unique expertise and experiences to Talkiatry, as well as his additional training in Women’s Mental Health, Reproductive and Perinatal Psychiatry, PTSD, and trauma-informed ADHD evaluation and treatment.

Dr. AJ’s approach focuses on behavioral change, with medication management and supportive therapies serving as important (and often essential) adjuvants to optimizing mental health.

During your first meetings with Dr. AJ, you should expect a thorough evaluation of your clinical and social histories, as well as some introductory psychoeducation.  Following that screening, anticipate a discussion about his approach to your condition and an initial treatment plan.  Please feel free to bring up any questions or concerns at any time during this process, and note-taking is highly encouraged!

‍

Dr. Micah Turpeau, is a board-certified psychiatrist with experience in both outpatient and inpatient settings. She earned her medical degree from Meharry Medical College and completed her psychiatry residency and child & adolescent psychiatry fellowship at the University of Florida College of Medicine – Jacksonville. Her training and practice reflect a commitment to supporting patients across the lifespan with individualized, evidence-based care.

Dr. Turpeau strives to create a safe, judgment-free space where patients can share their experiences openly. She encourages honest dialogue so patients feel supported, understood, and fully involved in every decision. Her approach emphasizes evidence-based medication management to reduce symptoms and improve functioning, while maintaining flexibility to adapt strategies as needs and goals evolve.

Dr. Turpeau begins with a collaborative exploration of symptoms, personal history, and goals to establish a clear treatment direction. She tailors care to each individual, balancing medication management with supportive therapy when appropriate. Through shared decision-making, She ensures patients remain active participants in their treatment. By closely monitoring progress and adjusting as needed, She provides care that is both responsive and effective.

Dr. Kyle Baird, DO, earned his medical degree from A.T. Still University – Kirksville College of Osteopathic Medicine and completed his psychiatry residency at the University of Colorado School of Medicine. He has practiced in diverse academic outpatient settings, using a multidisciplinary approach to understand clients and develop personalized treatment plans. He also served as medical director of a large academic outpatient clinic, overseeing psychiatrists, residents, psychology students, and advanced practitioners.

Dr. Baird values a holistic perspective in care, emphasizing empathy, understanding, and patient-centered treatment. He fosters open, clear communication and collaborates with clients to explore the causes of symptoms, as well as the strengths and behaviors that support resiliency and well-being. He also considers daily routines and life contexts that influence mental health.

During the initial appointment, Dr. Baird conducts a thorough evaluation of concerns, history, and functioning, completing any necessary screenings. He then develops a personalized treatment plan collaboratively, reviewing potential therapeutic interventions. Follow-up visits typically combine medication management, if appropriate, with brief psychotherapeutic support, adjusting intervals based on client needs, monitoring, and treatment progress.

Dr. Ramsey is board certified in general and child and adolescent psychiatry. His practice primarily focuses on medication management. He sees himself as a collaborator with therapists and counselors in caring for their shared patients and their families. He received his medical degree from the University of Tennessee Health Science Center in Memphis, TN. He completed his residency at West Virginia University Hospitals and WVU School of Medicine and a fellowship in child and adolescent psychiatry at the Yale Child Study Center, Yale University School of Medicine, and Yale-New Haven Hospital in New Haven and Middletown, CT. He completed his undergraduate studies at the University of Memphis. Dr. Ramsey remained in CT for two additional years, working in the Department of Children and Families, serving the state's at-risk youth and adolescents at a psychiatric residential treatment facility. He then returned to West Virginia University as clinical faculty in its School of Medicine. During the 12-year academic appointment, he had active roles in educating, training, and supervising medical students, general psychiatry residents, child and adolescent psychiatry fellows, and trainees from various disciplines. He worked for many years with adolescent males at both the Dually Diagnosed and Specialized Residential Treatment Centers within West Virginia University Healthcare. He provided outpatient and acute inpatient care, as well as hospital-based consultation services. Within the community, he provided medication evaluation and management services to residential treatment facilities and university student health. He has been seeing patients and collaborating with providers through telemedicine since 2016. While Dr. Ramsey specializes in working with patients with anxiety, he does not prescribe benzodiazepines.‍